1. Home
  2. SYBX vs RBOT Comparison

SYBX vs RBOT Comparison

Compare SYBX & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synlogic Inc.

SYBX

Synlogic Inc.

N/A

Current Price

$1.14

Market Cap

15.2M

Sector

Health Care

ML Signal

N/A

Logo Vicarious Surgical Inc.

RBOT

Vicarious Surgical Inc.

N/A

Current Price

$2.04

Market Cap

16.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SYBX
RBOT
Founded
N/A
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2M
16.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SYBX
RBOT
Price
$1.14
$2.04
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
77.3K
164.2K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$2.00
52 Week High
$1.96
$18.97

Technical Indicators

Market Signals
Indicator
SYBX
RBOT
Relative Strength Index (RSI) 39.17 26.59
Support Level $1.14 $2.16
Resistance Level $1.28 $2.33
Average True Range (ATR) 0.07 0.22
MACD 0.02 0.01
Stochastic Oscillator 59.26 0.00

Price Performance

Historical Comparison
SYBX
RBOT

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About RBOT Vicarious Surgical Inc.

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.

Share on Social Networks: